Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 1, 2015, Pages 72-80

  Plasschaert, Ellen ^a,b   Descheemaeker, Mie Jef ^a,b   Van Eylen, Lien ^a   Noens, Ilse ^a   Steyaert, Jean ^a,b,c   Legius, Eric ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ASD; Children social behavior questionnaire; NF1; Social; Social responsiveness scale

Indexed keywords

ADOLESCENT; ARTICLE; AUTISM; AUTISM ASSESSMENT; BEHAVIOR ASSESSMENT; CHILD; CHILDHOOD DISEASE; CHILDREN SOCIAL BEHAVIOR QUESTIONNAIRE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; COMPREHENSION; COMPULSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DONKEY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROFIBROMATOSIS; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SOCIAL BEHAVIOR; SOCIAL COGNITION; SOCIAL PARTICIPATION; SOCIAL PROBLEM; SOCIAL RESPONSIVENESS SCALE; SYMPTOMATOLOGY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION; COMPLICATION; GENETICS; MENTAL DISEASE; NEUROFIBROMATOSIS 1; PRESCHOOL CHILD; PSYCHOLOGY;

ADOLESCENT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COGNITION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEUROFIBROMATOSIS 1; QUESTIONNAIRES;

EID: 84919459048     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32280     Document Type: Article

References (31)

1. Adviento B, Corbin IL, Widjaja F, Desachy G, Enrique N, Rosser T, Risi S, Marco EJ, Hendren RL, Bearden CE, Rauen KA, Weiss LA. 2014. Autism traits in the RASopathies. J Med Genet 51(1):10-20.
2. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing.
3. Barton B, North K. 2004. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol 46(8):553-563.
4. Constantino JN, Gruber CP. 2005. Social Responsiveness Scale. Los Angeles: Western Psychological Services.
5. Dilts CV, Carey JC, Kircher JC, Hoffman RO, Creel D, Ward K, Clark E, Leonard CO. 1996. Children and adolescents with neurofibromatosis 1: A behavioral phenotype. J Dev Behav Pediatr 17(4):229-239.
6. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. 2010. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet Part A 152A:327-332.
7. Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, Green J. 2013a. Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study. Dev Med Child Neurol 55:139-145.
8. Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, Huson SM. 2013b. Neurofibromatosis Type 1 and Autism Spectrum Disorder. Pediatrics 132(6):e1642-e1648.
9. Garwood MM, Bernacki JM, Fine KM, Hainsworth KR, Davies WH, Klein-Tasman BP. 2012. Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1. Pain Res Treat 975364.
10. Graf A, Landolt MA, Mori AC, Boltshauser E. 2006. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr 149(3):348-353.
11. Huijbregts S, Jahja R, De Sonneville L, de Breij S, Swaab-Barneveld H. 2010. Social information processing in children and adolescents with neurofibromatosis type 1. Dev Med Child Neurol 52:620-625.
12. Huijbregts SC, de Sonneville LM. 2011. Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1. Behav Genet 41:430-436.
13. Hyman SL, Shores A, North KN. 2005. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65:1037-1044.
14. Johnson NS, Saal HM, Lovell AM, Schorry EK. 1999. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr 134:767-772.
15. Johnson H, Wiggs L, Stores G, Huson SM. 2005. Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol 47:237-242.
16. Kayl AE, Moore BD 3rd. 2000. Behavioural phenotype of neurofibromatosis type 1. Ment Retard Dev Disabil Res Rev 6:117-124.
17. Klein-Tasman BP, Li-Barber KT, Magargee ET. 2011. Honing in on the social phenotype in Williams syndrome using multiple measures and multiple raters. J Autism Dev Disord 41(3):341-351.
18. Klein-Tasman BP, Janke KM, Luo W, Casnar CL, Hunter SJ, Tonsgard J, Trapane P, van der Fluit F, Kais LA. 2014. Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. J Int Neuropsychol Soc. 20(1):88-98.
19. Levitt P, Campbell DB. 2009. Review series: The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 119:747-754.
20. Lord C, Rutter M, DiLavore PC, Risi S. 2003. Autism Diagnostic Observation Schedule, ADOS (Nederlandse vertaling de Bildt A & de Jonge M). Los Angeles, California: Western Psychological Services.
21. Lord C, Rutter M, DiLavore PC, Risi S, Gotham K, Bishop SL. 2012. Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual (Part 1): Modules 1-4. Torrance. California: Western Psychological Services.
22. Luteijn EF, Minderaa RB, Jackson AJ. 2002. Vragenlijst voor Inventarisatie van Sociaal gedrag bij Kinderen, Handleiding. Lisse: Swets & Zeitlinger.
23. Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B. 2012. Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with cognitive, disease, and environmental variables. J Pediatr Psychol 37(7):713-724.
24. Mautner VF, Kluwe L, Thakker SD, Leark RA. 2002. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol 44:164-170.
25. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda. Md. USA. July 13-15. 1987. Neurofibromatosis 1988. 1:172-178.
26. Noll RB, Reiter-Purtill J, Moore BD, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA. 2007. Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A 143A(19):2261-2273.
27. Payne JM. 2013. Autism spectrum disorder symptomatology in children with neurofibromatosis type 1. Dev Med Child Neurol 55(2):100-101.
28. Roeyers H, Thys M, Druart C, De Schryver M, Schittekatte M. 2011. Screeningslijst voor autismespecturmstoornissen. Handleiding. Amsterdam: Hogrefe Uitgevers.
29. Tinker J, Carbone PS, Viskochil D, Mathiesen A, Ma KN, Stevenson DA. 2014. Screening children with neurofibromatosis type 1 for autism spectrum disorder. Am J Med Genet A DOI: 10.1002/ajmg.a.36549.
30. van Eeghen AM, Pulsifer MB, Merker VL, Neumeyer AM, van Eeghen EE, Thibert RL, Cole AJ, Leigh FA, Plotkin SR, Thiele EA. 2013. Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach. Dev Med Child Neurol. 55(2):146-153.
31. Walsh KS, Vélez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT. 2013. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol 55:131-138.